Exact Mass: 452.2801

Exact Mass Matches: 452.2801

Found 120 metabolites which its exact mass value is equals to given mass value 452.2801, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

1-Cycloheptyl-1-(9H-fluoren-2-ylmethyl)-3-(2,4,6-trimethylphenyl)urea

N-Cycloheptyl-N-[(9H-fluoren-2-yl)methyl]-n-(2,4,6-trimethylphenyl)carbamimidate

C31H36N2O (452.2827)


   

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C25H40O7 (452.2774)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C25H40O7 (452.2774)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5S,6E,8Z,11Z,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C25H40O7 (452.2774)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-3-(acetyloxy)-2-hydroxypropyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C25H40O7 (452.2774)


DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

(2S)-3-(acetyloxy)-2-hydroxypropyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C25H40O7 (452.2774)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.2774)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.2774)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Antiostatin B3

Antiostatin B3

C26H36N4O3 (452.2787)


   

Antiostatin B4

Antiostatin B4

C26H36N4O3 (452.2787)


   

Briarellin P

Briarellin P

C25H40O7 (452.2774)


   

Laserpitinol

Laserpitinol

C25H40O7 (452.2774)


   

methyl-13S-hydroxy-14R,15-diacetoxy-1(10)-ent-halimen-18-oate

methyl-13S-hydroxy-14R,15-diacetoxy-1(10)-ent-halimen-18-oate

C25H40O7 (452.2774)


   

grindelic acid 15-O-arabinoside

grindelic acid 15-O-arabinoside

C25H40O7 (452.2774)


   

14,15-Di-Ac,17-Me ester-13,14,15-Trihydroxy-7-labden-17-oic acid

14,15-Di-Ac,17-Me ester-13,14,15-Trihydroxy-7-labden-17-oic acid

C25H40O7 (452.2774)


   

Ecdysteron

Ecdysteron

C25H40O7 (452.2774)


   

C25H40O7

C25H40O7 (452.2774)


   

dothideomycetone B

dothideomycetone B

C25H40O7 (452.2774)


   

5,6-acetonylgrayanotoxin-I

5,6-acetonylgrayanotoxin-I

C25H40O7 (452.2774)


   

18-methylmalonyl-7alpha-hydroxy-methyltrineracetal

18-methylmalonyl-7alpha-hydroxy-methyltrineracetal

C25H40O7 (452.2774)


   

6alpha,8alpha,23,14,15-erythro-pentahydroxy-labd-13(21),17-dien-16,19-olide|6alpha,8alpha,23,14,15-threo-pentahydroxy-labd-13(21),17-dien-16,19-olide

6alpha,8alpha,23,14,15-erythro-pentahydroxy-labd-13(21),17-dien-16,19-olide|6alpha,8alpha,23,14,15-threo-pentahydroxy-labd-13(21),17-dien-16,19-olide

C25H40O7 (452.2774)


   

6beta,7beta,11beta,14beta,15beta-pentahydroxy-20-isoamoxy-7alpha,20-epoxy-ent-kaur-16-ene|hebeirubescensin F

6beta,7beta,11beta,14beta,15beta-pentahydroxy-20-isoamoxy-7alpha,20-epoxy-ent-kaur-16-ene|hebeirubescensin F

C25H40O7 (452.2774)


   

Tomentin

Tomentin

C25H40O7 (452.2774)


   

Ala His Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Ala His Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Ala His Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Ala His Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Ala Ile His Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Ala Ile His Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Ala Ile Ile His

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

Ala Ile Leu His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

Ala Leu His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Ala Leu His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Ala Leu Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

Ala Leu Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

His Ala Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747)


   

His Ala Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747)


   

His Ala Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747)


   

His Ala Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747)


   

His Ile Ala Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747)


   

His Ile Ala Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747)


   

His Ile Ile Ala

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-methylpentanamido]propanoic acid

C21H36N6O5 (452.2747)


   

His Ile Leu Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-methylpentanamido]propanoic acid

C21H36N6O5 (452.2747)


   

His Leu Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]propanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747)


   

His Leu Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]propanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747)


   

His Leu Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-methylpentanamido]propanoic acid

C21H36N6O5 (452.2747)


   

His Leu Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-4-methylpentanamido]propanoic acid

C21H36N6O5 (452.2747)


   

His Val Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylbutanamido]-3-methylbutanoic acid

C21H36N6O5 (452.2747)


   

Ile Ala His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Ile Ala His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Ile Ala Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

Ile Ala Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

Ile His Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Ile His Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Ile His Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanoic acid

C21H36N6O5 (452.2747)


   

Ile His Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]propanoic acid

C21H36N6O5 (452.2747)


   

Ile Ile Ala His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

Ile Ile His Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C21H36N6O5 (452.2747)


   

Ile Leu Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

Ile Leu His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C21H36N6O5 (452.2747)


   

Leu Ala His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Leu Ala His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Leu Ala Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

Leu Ala Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

Leu His Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Leu His Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-methylpentanoic acid

C21H36N6O5 (452.2747)


   

Leu His Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]propanoic acid

C21H36N6O5 (452.2747)


   

Leu His Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]propanoic acid

C21H36N6O5 (452.2747)


   

Leu Ile Ala His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

Leu Ile His Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C21H36N6O5 (452.2747)


   

Leu Leu Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

Leu Leu His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C21H36N6O5 (452.2747)


   

Val His Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanamido]-3-methylbutanoic acid

C21H36N6O5 (452.2747)


   

Val Val His Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylbutanoic acid

C21H36N6O5 (452.2747)


   

Val Val Val His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-methylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

Sarcoehrendin I

methyl-9S-hydroxy-11R,15S-diacetoxy-6Z,13E-prostadienoate

C25H40O7 (452.2774)


   

1-Propanol, 2-methoxy-3-[(9Z)-9-octadecenyloxy]-, dihydrogen phosphorothioate, (2R)

1-Propanol, 2-methoxy-3-[(9Z)-9-octadecenyloxy]-, dihydrogen phosphorothioate, (2R)

C22H45O5PS (452.2725)


   

1-hexadecyl-3-methylimidazolium hexafluorophosphate

1-hexadecyl-3-methylimidazolium hexafluorophosphate

C20H39F6N2P (452.2755)


   

R 5011 (dopant)

R 5011 (dopant)

C32H36O2 (452.2715)


   

1-Cycloheptyl-1-(9H-fluoren-2-ylmethyl)-3-(2,4,6-trimethylphenyl)urea

1-Cycloheptyl-1-(9H-fluoren-2-ylmethyl)-3-(2,4,6-trimethylphenyl)urea

C31H36N2O (452.2827)


YM-750 is a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor (IC50=0.18 μM). ACAT catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty-acyl-coenzyme A[1][2].

   

Butropium

Butropium

C28H38NO4+ (452.2801)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

N-hexadecanoyl-sn-glycero-3-phosphoethanolamine(1-)

N-hexadecanoyl-sn-glycero-3-phosphoethanolamine(1-)

C21H43NO7P- (452.2777)


   

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C25H40O7 (452.2774)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

C25H40O7 (452.2774)


   

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C25H40O7 (452.2774)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

C25H40O7 (452.2774)


   

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C25H40O7 (452.2774)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

C25H40O7 (452.2774)


   

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C25H40O7 (452.2774)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

C25H40O7 (452.2774)


   

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C25H40O7 (452.2774)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

C25H40O7 (452.2774)


   

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C25H40O7 (452.2774)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

C25H40O7 (452.2774)


   

Ala-Leu-Leu-His

Ala-Leu-Leu-His

C21H36N6O5 (452.2747)


A tetrapeptide composed of L-alanine, two L-leucine units, and an L-histidine joined in sequence.

   

epiandrosterone 3-beta-D-glucoside

epiandrosterone 3-beta-D-glucoside

C25H40O7 (452.2774)


A sterol 3-beta-D-glucoside that has epiandrosterone as the sterol component.

   

2-[[(2R)-2-acetyloxy-3-undec-10-enoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-2-acetyloxy-3-undec-10-enoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO7P+ (452.2777)


   

2-[hydroxy-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C21H43NO7P+ (452.2777)


   

lysophosphatidylethanolamine zwitterion 16:0

lysophosphatidylethanolamine zwitterion 16:0

C21H43NO7P (452.2777)


A lysophosphatidylethanolamine zwitterion in which the remaining acyl group (position not specified) contains 16 carbons and 0 double bonds.

   

ST 19:0;O;GlcA

ST 19:0;O;GlcA

C25H40O7 (452.2774)


   

ST 19:1;O2;Hex

ST 19:1;O2;Hex

C25H40O7 (452.2774)


   

ST 25:2;O7

ST 25:2;O7

C25H40O7 (452.2774)


   

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17s)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17s)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.2774)


   

(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-3-(3h-imidazol-4-yl)propanoic acid

(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-3-(3h-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)


   

12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

C25H40O7 (452.2774)


   

15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.2774)


   

(1r,2s,3s,5s,7r,8r,9s,10s,11r,16s,18r)-12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

(1r,2s,3s,5s,7r,8r,9s,10s,11r,16s,18r)-12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

C25H40O7 (452.2774)


   

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5s)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5s)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O7 (452.2774)


   

(1r,4ar,5s,8s,8ar)-5-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a,6-trimethyl-8-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

(1r,4ar,5s,8s,8ar)-5-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a,6-trimethyl-8-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

C25H40O7 (452.2774)


   

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5r)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5r)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O7 (452.2774)


   

1-{7-hydroxy-5-[2-(5-methoxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methyl 3-methyl propanedioate

1-{7-hydroxy-5-[2-(5-methoxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methyl 3-methyl propanedioate

C25H40O7 (452.2774)


   

(1s,2e,4s,6e)-1-[(1r,2s,5r,6s)-5-hydroxy-4-(hydroxymethyl)-2-[(2-hydroxypropan-2-yl)oxy]-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-3,7,11-trimethyldodeca-2,6,10-triene-1,4-diol

(1s,2e,4s,6e)-1-[(1r,2s,5r,6s)-5-hydroxy-4-(hydroxymethyl)-2-[(2-hydroxypropan-2-yl)oxy]-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-3,7,11-trimethyldodeca-2,6,10-triene-1,4-diol

C25H40O7 (452.2774)


   

(1r,2s,5r,6s)-1-[(1s,2e,4s,6e)-1,4-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-4-{[(2-hydroxypropan-2-yl)oxy]methyl}-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol

(1r,2s,5r,6s)-1-[(1s,2e,4s,6e)-1,4-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-4-{[(2-hydroxypropan-2-yl)oxy]methyl}-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol

C25H40O7 (452.2774)


   

5-(3-hydroxy-3-methylpent-4-en-1-yl)-1,4a,6-trimethyl-8-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

5-(3-hydroxy-3-methylpent-4-en-1-yl)-1,4a,6-trimethyl-8-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

C25H40O7 (452.2774)


   

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17r)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17r)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.2774)